| scholarly article | Q13442814 |
| P50 | author | Bradley Hyman | Q23303113 |
| Susanne Wegmann | Q87854356 | ||
| Rachel E Bennett | Q93091636 | ||
| Danny McKenzie | Q93091640 | ||
| Molly J Kirk | Q93091643 | ||
| Ana C Amaral | Q93091645 | ||
| P2093 | author name string | Eloise Hudry | |
| Zhanyun Fan | |||
| Julia Schiantarelli | |||
| Nahel Tunio | |||
| Louis Delorme | |||
| Miwei Hu | |||
| Samantha Nicholls | |||
| Ashley B Robbins | |||
| P2860 | cites work | Transmission and spreading of tauopathy in transgenic mouse brain | Q24651334 |
| Depletion of microglia and inhibition of exosome synthesis halt tau propagation | Q27311815 | ||
| Trans-synaptic spread of tau pathology in vivo | Q28732288 | ||
| Tau-mediated synaptic damage in Alzheimer's disease | Q28831067 | ||
| Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease | Q29617286 | ||
| Propagation of tau pathology in a model of early Alzheimer's disease | Q29620203 | ||
| Glial contributions to neurodegeneration in tauopathies | Q32173558 | ||
| Tau promotes neurodegeneration through global chromatin relaxation | Q33575083 | ||
| Proteopathic tau seeding predicts tauopathy in vivo. | Q34383788 | ||
| Chaperones increase association of tau protein with microtubules | Q34470626 | ||
| A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity | Q34616539 | ||
| Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy | Q35053727 | ||
| Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections | Q35985428 | ||
| Transgenic animal models of tauopathies | Q35992159 | ||
| Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity | Q36394952 | ||
| Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy | Q36617500 | ||
| Neuronal activity enhances tau propagation and tau pathology in vivo. | Q37127500 | ||
| Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice | Q37415258 | ||
| Protein Quality Control by Molecular Chaperones in Neurodegeneration | Q37739093 | ||
| ECM in brain aging and dementia | Q38269694 | ||
| 2016 Alzheimer's disease facts and figures | Q39444315 | ||
| Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses | Q40052866 | ||
| Staging of Alzheimer's disease-related neurofibrillary changes | Q40416705 | ||
| Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody. | Q40854182 | ||
| Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies | Q41760966 | ||
| Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis | Q42288828 | ||
| The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease | Q42470207 | ||
| Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector | Q45874327 | ||
| Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons. | Q48127231 | ||
| Changes in neuronal DNA content variation in the human brain during aging | Q48563741 | ||
| The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. | Q53215353 | ||
| Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways. | Q55000106 | ||
| Inert and seed-competent tau monomers suggest structural origins of aggregation. | Q55715541 | ||
| Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure | Q60603641 | ||
| TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. | Q64928623 | ||
| Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. | Q64982207 | ||
| Unconventional Secretion Mediates the Trans-cellular Spreading of Tau | Q88693640 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P304 | page(s) | eaaw6404 | |
| P577 | publication date | 2019-06-26 | |
| P1433 | published in | Science Advances | Q19881044 |
| P1476 | title | Experimental evidence for the age dependence of tau protein spread in the brain | |
| P478 | volume | 5 |
| Q99608983 | Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation |
| Q101135994 | Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes |
| Q89598886 | Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases |
| Q92017756 | Glycine-alanine dipeptide repeats spread rapidly in a repeat length- and age-dependent manner in the fly brain |
| Q91647353 | Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs |
| Q91971770 | LRP1 is a master regulator of tau uptake and spread |
Search more.